Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia
Author(s) -
Marianthi Georgitsi,
Anniina Raitila,
Auli Karhu,
Rob B. van der Luijt,
Cora M. Aalfs,
Timo Sane,
Outi Vierimaa,
Markus J. Mäkinen,
Karoliina Tuppurainen,
R Paschke,
Oliver Gimm,
Christian A. Koch,
Sadi Gündoğdu,
Anneke Lucassen,
Marc Tischkowitz,
Louise Izatt,
Simon Aylwin,
Gul Bano,
Shirley Hodgson,
Ernesto De Menis,
Virpi Laun,
Pia Vahteristo,
Lauri A. Aaltonen
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-2843
Subject(s) - men1 , multiple endocrine neoplasia , pituitary adenoma , germline mutation , germline , acromegaly , pituitary tumors , cancer research , adenoma , medicine , mutation , genetics , biology , gene , hormone , growth hormone
Germline mutations in the MEN1 gene predispose to multiple endocrine neoplasia type 1 (MEN1) syndrome, but in up to 20-25% of clinical MEN1 cases, no MEN1 mutations can be found. Recently, a germline mutation in the CDKN1B gene, encoding p27(Kip1), was reported in one suspected MEN1 family with two acromegalic patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom